profit from every $100 of sales.
$0$100
Advanced Biomed
$2.32+9.95% today
-73.1% in 1 year
1-year low $1.901-year high $18.98
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Advanced Biomed sold, what it kept, and what it did with the cash.
Sales went from $0 in 2021 to $0 in 2024, with -$2.78 million of profit last year.
SalesProfit
Advanced Biomed vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Advanced Biomed | No profit yet | ||
 Illumina | 37.9× · Expensive | ||
 Labcorp Holdings | 34.5× · Expensive | ||
 Quest Diagnostics | 28.8× · Fair price | ||
 Guardant Health | No profit yet |
AI analysis
An AI analyst reads Advanced Biomed's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -2 | -2 | -3 | -3 | |
| -2 | -2 | -3 | -2 | |
| -2 | -4 | -4 | -3 | |
| – | -0.64 | -3.45 | -2.57 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 | 7 | 5 | 4 |
| Cash | 0 | 5 | 3 | 3 |
| Total debt | 0 | 0 | 0 | 0 |
| Total liabilities | 0 | 3 | 3 | 3 |
| 1 | 3 | 1 | 2 | |
| – | 6 | 6 | 1 | |
| -147.6% | -47.4% | -157.5% | -112.2% | |
| -188.2% | -115.4% | -285.9% | -167.3% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| -0 | -1 | -3 | -2 | |
| 0 | 1 | 0 | 0 | |
| -0 | -2 | -3 | -2 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- –
- –
- –
- 14.1×
- –
- –
- –
- -4.8%
- 0.0%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -16.9%
- -136.9%
- 100.8%
- 46.7%
- -17.9%
- –
Growth
- –
- –
- +91.7%
- –
- −1.3%
Financial health
- 1.8×
- 0.00
- 0.2%
- –
- 8.56
- 8.55
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 21%of 958
Bottom 21%of 888
Bottom 18%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -0.38 | – | – |
| Feb 13, 2026 | 0.32 | – | – |
| Nov 19, 2025 | -0.02 | – | – |
| Oct 8, 2025 | -0.03 | – | – |
| May 15, 2025 | -0.07 | – | – |
| Apr 15, 2025 | -0.04 | – | – |
| Sep 30, 2024 | -0.01 | – | – |
| Jun 30, 2024 | -0.93 | – | – |
News
FPT Becomes the World’s First Microsoft Partner to Earn Frontier Advanced SpecializationYahoo Finance · Nov 12, 2026Stock Market Today, Nov. 11: Advanced Micro Devices Jumps -- and Not Only Because of CoreWeave's ResultsYahoo Finance · Nov 11, 2026The Zacks Analyst Blog Highlights Arista Networks, Fabrinet, Analog Devices, Advanced Micro Devices and NVIDIAYahoo Finance · Nov 11, 2026Nvidia’s China Spy Fallout Deepens: Report Says Moonshot AI Accessed NVDA’s Advanced Chips Despite Export ControlsYahoo Finance · Nov 10, 2026Nvidia Is Reportedly Pouring Billions Into AI's Next Big Bottleneck: Advanced Chip PackagingYahoo Finance · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
22No pass
Benjamin Graham
40No pass
Philip Fisher
38No pass
Peter Lynch
60Pass
Joel Greenblatt
0No pass
Charlie Munger
31No pass
Terry Smith
29No pass
Questions about Advanced Biomed
Is Advanced Biomed a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Advanced Biomed AI analysis
What does Advanced Biomed do?
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. It is in Medical - Diagnostics & Research.
Does Advanced Biomed pay a dividend?
No. Advanced Biomed does not pay a dividend at the moment.
Is Advanced Biomed stock halal?
No. Advanced Biomed does not pass our halal screen: its cash and confirmed interest-bearing investments are 68% of its market value, at or above the 33% limit. How we check
How has Advanced Biomed stock done over the past year?
Down 73.1% over the past twelve months, to $2.32. It traded between $1.90 and $18.98 and is 87.8% below its high.
Who are Advanced Biomed's competitors?
The largest listed companies in the same industry are Illumina, Labcorp Holdings, Quest Diagnostics and Guardant Health. The peers table on this page compares their profit, growth and price with Advanced Biomed's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.